-
1 Comment
Data Horizon Corporation is currently in a long term uptrend where the price is trading 5.0% above its 200 day moving average.
From a valuation standpoint, the stock is 91.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.1.
Data Horizon Corporation's total revenue rose by 56.8% to $417M since the same quarter in the previous year.
Its net income has increased by 18.2% to $-133M since the same quarter in the previous year.
Based on the above factors, Data Horizon Corporation gets an overall score of 4/5.
| ISIN | JP3548730005 |
|---|---|
| Exchange | TSE |
| CurrencyCode | JPY |
| Sector | Healthcare |
| Industry | Health Information Services |
| PE Ratio | None |
|---|---|
| Target Price | None |
| Market Cap | 7B |
| Beta | 0.31 |
| Dividend Yield | None |
Data Horizon Co.,Ltd. engages in the development and provision of medical information services in Japan. It offers services, such as data health planning and analysis for planning; projects related to specific health checkups; prevention of aggravation; medical consultation behavior; encouragement to visit a medical institution; promoting the use of generic drugs; and optimizing drug use. The company was founded in 1981 and is headquartered in Hiroshima, Japan. Data Horizon Co.,Ltd. operates as a subsidiary of DeNA Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3628.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
